Telomir Pharmaceuticals prices $5.6 million PIPE at $1.16 per share
Telomir Pharmaceuticals priced a $5.6 million PIPE, issuing 4,843,300 common shares at $1.16 each, a 5% discount to VWAP. John Paul DeJoria invested an additional $1 million. Proceeds are for Telomir-Zn clinical development.